The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems
Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin...
Saved in:
Published in | Scientific reports Vol. 11; no. 1; pp. 16983 - 18 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
20.08.2021
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin Resistance (IR) and its complications. In the present study, we show that intramuscular injection of P-MSCs homed more towards the visceral site, restored HOMA-IR and glucose homeostasis in the WNIN/GR-Ob (Ob-T2D) rats. P-MSC therapy was effective in re-establishing the dysregulated cytokines. We report that the P-MSCs activates PI3K-Akt signaling and regulates the Glut4-dependant glucose uptake and its utilization in WNIN/GR-Ob (Ob-T2D) rats compared to its control. Our data reinstates P-MSC treatment's potent application to alleviate IR and restores peripheral blood glucose clearance evidenced in stromal vascular fraction (SVF) derived from white adipose tissue (WAT) of the WNIN/GR-Ob rats. Gaining insights, we show the activation of the PI3K-Akt pathway by P-MSCs both in vivo and in vitro (palmitate primed 3T3-L1 cells) to restore the insulin sensitivity dysregulated adipocytes. Our findings suggest a potent application of P-MSCs in pre-clinical/Ob-T2D management. |
---|---|
AbstractList | Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin Resistance (IR) and its complications. In the present study, we show that intramuscular injection of P-MSCs homed more towards the visceral site, restored HOMA-IR and glucose homeostasis in the WNIN/GR-Ob (Ob-T2D) rats. P-MSC therapy was effective in re-establishing the dysregulated cytokines. We report that the P-MSCs activates PI3K-Akt signaling and regulates the Glut4-dependant glucose uptake and its utilization in WNIN/GR-Ob (Ob-T2D) rats compared to its control. Our data reinstates P-MSC treatment's potent application to alleviate IR and restores peripheral blood glucose clearance evidenced in stromal vascular fraction (SVF) derived from white adipose tissue (WAT) of the WNIN/GR-Ob rats. Gaining insights, we show the activation of the PI3K-Akt pathway by P-MSCs both in vivo and in vitro (palmitate primed 3T3-L1 cells) to restore the insulin sensitivity dysregulated adipocytes. Our findings suggest a potent application of P-MSCs in pre-clinical/Ob-T2D management. Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin Resistance (IR) and its complications. In the present study, we show that intramuscular injection of P-MSCs homed more towards the visceral site, restored HOMA-IR and glucose homeostasis in the WNIN/GR-Ob (Ob-T2D) rats. P-MSC therapy was effective in re-establishing the dysregulated cytokines. We report that the P-MSCs activates PI3K-Akt signaling and regulates the Glut4-dependant glucose uptake and its utilization in WNIN/GR-Ob (Ob-T2D) rats compared to its control. Our data reinstates P-MSC treatment's potent application to alleviate IR and restores peripheral blood glucose clearance evidenced in stromal vascular fraction (SVF) derived from white adipose tissue (WAT) of the WNIN/GR-Ob rats. Gaining insights, we show the activation of the PI3K-Akt pathway by P-MSCs both in vivo and in vitro (palmitate primed 3T3-L1 cells) to restore the insulin sensitivity dysregulated adipocytes. Our findings suggest a potent application of P-MSCs in pre-clinical/Ob-T2D management. Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin Resistance (IR) and its complications. In the present study, we show that intramuscular injection of P-MSCs homed more towards the visceral site, restored HOMA-IR and glucose homeostasis in the WNIN/GR-Ob (Ob-T2D) rats. P-MSC therapy was effective in re-establishing the dysregulated cytokines. We report that the P-MSCs activates PI3K-Akt signaling and regulates the Glut4-dependant glucose uptake and its utilization in WNIN/GR-Ob (Ob-T2D) rats compared to its control. Our data reinstates P-MSC treatment's potent application to alleviate IR and restores peripheral blood glucose clearance evidenced in stromal vascular fraction (SVF) derived from white adipose tissue (WAT) of the WNIN/GR-Ob rats. Gaining insights, we show the activation of the PI3K-Akt pathway by P-MSCs both in vivo and in vitro (palmitate primed 3T3-L1 cells) to restore the insulin sensitivity dysregulated adipocytes. Our findings suggest a potent application of P-MSCs in pre-clinical/Ob-T2D management.Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin Resistance (IR) and its complications. In the present study, we show that intramuscular injection of P-MSCs homed more towards the visceral site, restored HOMA-IR and glucose homeostasis in the WNIN/GR-Ob (Ob-T2D) rats. P-MSC therapy was effective in re-establishing the dysregulated cytokines. We report that the P-MSCs activates PI3K-Akt signaling and regulates the Glut4-dependant glucose uptake and its utilization in WNIN/GR-Ob (Ob-T2D) rats compared to its control. Our data reinstates P-MSC treatment's potent application to alleviate IR and restores peripheral blood glucose clearance evidenced in stromal vascular fraction (SVF) derived from white adipose tissue (WAT) of the WNIN/GR-Ob rats. Gaining insights, we show the activation of the PI3K-Akt pathway by P-MSCs both in vivo and in vitro (palmitate primed 3T3-L1 cells) to restore the insulin sensitivity dysregulated adipocytes. Our findings suggest a potent application of P-MSCs in pre-clinical/Ob-T2D management. Abstract Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin Resistance (IR) and its complications. In the present study, we show that intramuscular injection of P-MSCs homed more towards the visceral site, restored HOMA-IR and glucose homeostasis in the WNIN/GR-Ob (Ob-T2D) rats. P-MSC therapy was effective in re-establishing the dysregulated cytokines. We report that the P-MSCs activates PI3K-Akt signaling and regulates the Glut4-dependant glucose uptake and its utilization in WNIN/GR-Ob (Ob-T2D) rats compared to its control. Our data reinstates P-MSC treatment's potent application to alleviate IR and restores peripheral blood glucose clearance evidenced in stromal vascular fraction (SVF) derived from white adipose tissue (WAT) of the WNIN/GR-Ob rats. Gaining insights, we show the activation of the PI3K-Akt pathway by P-MSCs both in vivo and in vitro (palmitate primed 3T3-L1 cells) to restore the insulin sensitivity dysregulated adipocytes. Our findings suggest a potent application of P-MSCs in pre-clinical/Ob-T2D management. |
ArticleNumber | 16983 |
Author | Nemani, Harishankar Venkatesan, Vijayalakshmi Mungamuri, Sathish Kumar Kotikalapudi, Nagasuryaprasad Sukesh Narayan, Sinha R., Bhonde Sampath, Samuel Joshua Pragasam |
Author_xml | – sequence: 1 givenname: Nagasuryaprasad surname: Kotikalapudi fullname: Kotikalapudi, Nagasuryaprasad organization: Division of Cell and Molecular Biology, ICMR-National Institute of Nutrition – sequence: 2 givenname: Samuel Joshua Pragasam surname: Sampath fullname: Sampath, Samuel Joshua Pragasam organization: Division of Cell and Molecular Biology, ICMR-National Institute of Nutrition – sequence: 3 givenname: Sinha surname: Sukesh Narayan fullname: Sukesh Narayan, Sinha organization: Division of Food Safety, ICMR-National Institute of Nutrition – sequence: 4 givenname: Bhonde surname: R. fullname: R., Bhonde organization: Department of Regenerative Medicine, Manipal Institute of Regenerative Medicine, Dr. D. Y. Patil Vidyapeeth – sequence: 5 givenname: Harishankar surname: Nemani fullname: Nemani, Harishankar organization: Division of Animal Facility, ICMR-National Institute of Nutrition – sequence: 6 givenname: Sathish Kumar surname: Mungamuri fullname: Mungamuri, Sathish Kumar organization: Division of Food Safety, ICMR-National Institute of Nutrition – sequence: 7 givenname: Vijayalakshmi surname: Venkatesan fullname: Venkatesan, Vijayalakshmi email: v.venkateshan@gmail.com organization: Division of Cell and Molecular Biology, ICMR-National Institute of Nutrition |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34417511$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1v3CAQhq0qVZOm-QM9VEi9pAe3fBmbHiJVUT8iReolPSMM410iG7bArrTH_vPiddImOYQDIHjfh2FmXldHPnioqrcEfySYdZ8SJ43sakxJLQUpM35RnVDMm5oySo8e7I-rs5RucRkNlZzIV9Ux45y0DSEn1Z-bNaBNDJNLcJ4-oDCgCRJ4s95PekQpw4QMjCPKa4h6s0fOI72DmJ1fFR-Y0XlnitI63UOG9BmNkFLwCQ2FOst3bheQ9nbZ5xjQFCwU9n6mpzfVy0GPCc7u1tPq17evN5c_6uuf368uv1zXpuE415YazAjtWtxR2g2W9VoAM0LIQWDamN4a3XJJZa81NdZgPZRZc44ta4S27LS6Wrg26Fu1iW7Sca-CdupwEOJK6fItM4LC1hrTYDxwDrynohM9lwO0JWXQcqCFdbGwNtt-AmvA56jHR9DHN96t1SrsVMdaWQpTAOd3gBh-byFlVQow51l7CNukaCMYp4TJ-a33T6S3YRt9SdVBhQWVrSyqdw8j-hfKfaWLoFsEJoaUIgzKuKyzC3OAblQEq7mv1NJXqvSVOvSVwsVKn1jv6c-a2GJKRexXEP-H_YzrL-qr4YQ |
CitedBy_id | crossref_primary_10_1007_s13577_021_00664_3 crossref_primary_10_61865_j_cyfsld_2024_mee0_h72k crossref_primary_10_3889_oamjms_2022_8211 crossref_primary_10_54033_cadpedv21n12_072 crossref_primary_10_1007_s00441_022_03693_y |
Cites_doi | 10.2337/db05-1574 10.2337/diacare.2951096 10.1038/onc.2014.198 10.2337/diacare.27.9.2253 10.1172/jci93558 10.1039/C8RA08272C 10.1016/j.cell.2012.02.017 10.1210/jcem.85.9.6839 10.1001/archinternmed.2009.508 10.1186/s13287-016-0420-2 10.1155/2013/617569 10.1016/j.celrep.2017.11.085 10.1074/jbc.M301977200 10.4331/wjbc.v8.i2.120 10.1210/en.2011-0288 10.1038/s41536-019-0083-6 10.1038/nrendo.2012.114 10.1016/s0140-6736(10)60408-4 10.18632/oncotarget.20442 10.1080/19382014.2014.998099 10.1016/j.lfs.2017.06.016 10.1016/b978-0-12-416618-9.00005-4 10.2217/17460875.3.5.545 10.2337/diabetes.51.7.2074 10.1007/s11684-011-0116-z 10.1210/en.2003-1336 10.1038/nbt.2978 10.1159/000480525 10.1370/afm.343 10.1177/0963689719837897 10.1002/med.20010 10.2337/diabetes.49.12.2063 10.1172/jci92035 10.3858/emm.2011.43.10.069 10.2147/dmso.S236127 10.1101/cshperspect.a029801 10.3390/ijms18050959 10.1074/jbc.M112.361386 10.1073/pnas.0608249103 10.2337/dc07-1593 10.3389/fendo.2017.00006 10.1074/jbc.M110.213108 10.1016/j.phrs.2018.04.002 10.2337/db15-0278 10.1016/j.mce.2009.08.007 10.3389/fimmu.2014.00470 10.3389/fimmu.2014.00491 10.2337/db15-1122 10.1038/cddis.2015.327 10.1073/pnas.1500396113 10.1155/2017/5076732 10.1016/j.ymthe.2018.06.013 10.7554/eLife.26896 10.1016/j.cell.2017.07.029 10.1016/j.cell.2011.04.029 10.1097/MED.0b013e3283514e13 10.1172/jci36284 10.1016/j.cels.2018.06.003 10.1016/j.celrep.2016.02.049 10.1038/nrendo.2009.62 10.1007/s00125-017-4342-z 10.1111/dom.12610 10.1038/nm.4350 10.5223/pghn.2013.16.3.143 10.2337/db11-1141 10.1210/jcem.83.3.4660 10.4252/wjsc.v6.i2.82 10.3389/fendo.2016.00030 10.1111/j.1365-2567.2006.02321.x 10.1161/01.Atv.0000201938.78044.75 10.1016/j.molmet.2019.06.013 10.1002/stem.1681 10.2337/diacare.27.6.1487 10.1900/rds.2010.7.168 10.1530/jme-17-0311 10.1186/s13287-017-0598-y 10.1186/s13287-020-1578-1 10.1371/journal.pone.0048061 10.1016/j.cmet.2013.05.001 10.3390/cancers11010024 10.1097/med.0000000000000170 10.3389/fcell.2020.00016 10.1038/s41366-019-0438-5 10.1007/s40273-014-0243-x 10.1016/j.cellimm.2017.03.001 10.1016/j.tem.2019.04.011 |
ContentType | Journal Article |
Copyright | The Author(s) 2021. corrected publication 2021 2021. The Author(s). The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021, corrected publication 2021 |
Copyright_xml | – notice: The Author(s) 2021. corrected publication 2021 – notice: 2021. The Author(s). – notice: The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021, corrected publication 2021 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1038/s41598-021-96121-0 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest : Biological Science Collection journals [unlimited simultaneous users] ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 18 |
ExternalDocumentID | oai_doaj_org_article_0ddcc500f44e4b2686b49fe7751e74e2 PMC8379204 34417511 10_1038_s41598_021_96121_0 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Indian Council of Medical Research grantid: 15-BS03 funderid: http://dx.doi.org/10.13039/501100001411 – fundername: ; grantid: 15-BS03 |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c540t-d2c03128708228fd3ba6e3c669f6025cbdca74929baa2cdc0afcdca440d356ad3 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Wed Aug 27 01:31:05 EDT 2025 Thu Aug 21 14:01:54 EDT 2025 Fri Jul 11 03:21:55 EDT 2025 Wed Aug 13 06:11:02 EDT 2025 Thu Jan 02 22:39:40 EST 2025 Tue Jul 01 03:49:11 EDT 2025 Thu Apr 24 23:00:36 EDT 2025 Fri Feb 21 02:39:12 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2021. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-d2c03128708228fd3ba6e3c669f6025cbdca74929baa2cdc0afcdca440d356ad3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-96121-0 |
PMID | 34417511 |
PQID | 2563062979 |
PQPubID | 2041939 |
PageCount | 18 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0ddcc500f44e4b2686b49fe7751e74e2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8379204 proquest_miscellaneous_2563421392 proquest_journals_2563062979 pubmed_primary_34417511 crossref_citationtrail_10_1038_s41598_021_96121_0 crossref_primary_10_1038_s41598_021_96121_0 springer_journals_10_1038_s41598_021_96121_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-08-20 |
PublicationDateYYYYMMDD | 2021-08-20 |
PublicationDate_xml | – month: 08 year: 2021 text: 2021-08-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Wang (CR89) 2006; 55 Baek, Kang, Ra (CR51) 2011; 43 Hardy, Czech, Corvera (CR8) 2012; 19 Harishankar, Vajreswari, Giridharan (CR24) 2011; 134 Samuel, Petersen, Shulman (CR7) 2010; 375 Lee (CR54) 2012; 287 Venkatesan (CR25) 2013; 2013 Saltiel, Olefsky (CR2) 2017; 127 Li (CR81) 2016; 7 Fève, Bastard (CR65) 2009; 5 Lecube, Hernández, Genescà, Simó (CR84) 2006; 29 Donath, Dalmas, Sauter, Böni-Schnetzler (CR61) 2013; 17 Singh (CR29) 2014; 6 Madhira (CR36) 2012; 7 Mungamuri, Wang, Manfredi, Gu, Aaronson (CR90) 2015; 34 Gao (CR27) 2016; 7 Nasri, Rafieian-Kopaei (CR56) 2014; 19 Boden, Laakso (CR9) 2004; 27 Usmani-Brown (CR63) 2019; 27s Asghar, Sheikh (CR64) 2017; 315 Taylor, Verhagen, Blaser, Akdis, Akdis (CR67) 2006; 117 Pittenger (CR42) 2019; 4 Bastard (CR74) 2000; 85 Stanford, Goodyear (CR50) 2018 Mastri, Lin, Lee (CR45) 2014; 6 Lee, Lee, Choue (CR78) 2013; 16 Feng (CR6) 2020; 13 Wallace, Levy, Matthews (CR30) 2004; 27 Polsky, Ellis (CR1) 2015; 22 Luo (CR18) 2016; 65 Vallés (CR52) 2020; 11 Lane, Williams, Watt (CR77) 2014; 32 Stafeev, Vorotnikov, Ratner, Menshikov, Parfyonova (CR5) 2017; 2017 Jiang (CR21) 2011; 5 Liu (CR26) 2011; 286 Pirola, Ferraz (CR62) 2017; 8 Wang, Song, Strange, Dong, Wang (CR71) 2018; 26 Wong (CR83) 2011; 152 Sarr (CR48) 2017 Fruman (CR37) 2017; 170 Argilés, López-Soriano, Almendro, Busquets, López-Soriano (CR49) 2005; 25 Chaudhury (CR19) 2017; 8 Ahima (CR31) 2008; 118 Leitner (CR4) 2017; 10 Beg, Abdullah, Thowfeik, Altorki, McGraw (CR57) 2017 Deacon, Lebovitz (CR20) 2016; 18 Hruby, Hu (CR3) 2015; 33 Si (CR70) 2012; 61 Hakuno, Takahashi (CR38) 2018; 61 Sell, Habich, Eckel (CR66) 2012; 8 Rotter, Nagaev, Smith (CR69) 2003; 278 Di Carlo, Peduto (CR76) 2018; 128 Kadam, Muthyala, Nair, Bhonde (CR22) 2010; 7 Levri (CR17) 2005; 3 Vijayalakshmi, Bamji (CR34) 1987; 24 Rena, Hardie, Pearson (CR13) 2017; 60 Choe, Huh, Hwang, Kim, Kim (CR10) 2016; 7 Tanner (CR35) 2018; 7 Fain, Madan, Hiler, Cheema, Bahouth (CR72) 2004; 145 Kraakman, Murphy, Jandeleit-Dahm, Kammoun (CR75) 2014; 5 Zheng (CR85) 2015; 112 Rabbani, Thornalley (CR60) 2019; 30 Jani (CR41) 2008; 31 Fried, Bunkin, Greenberg (CR73) 1998; 83 Jiang (CR88) 2019; 9 Arango Duque, Descoteaux (CR12) 2014; 5 Bora, Majumdar (CR33) 2017; 8 Samuel, Shulman (CR59) 2012; 148 Krycer (CR40) 2017; 21 Surmi, Hasty (CR11) 2008; 3 Scheel (CR44) 2011; 145 Hundal (CR14) 2000; 49 Liu (CR39) 2015; 64 Musi (CR15) 2002; 51 Mungamuri (CR86) 2016; 14 Lv, Tuan, Cheung, Leung (CR43) 2014; 32 Ryan (CR32) 2010; 170 Czech (CR58) 2017; 23 Kern (CR68) 2018 TeSlaa, Teitell (CR87) 2014; 542 Kamal, Kassem (CR28) 2020; 8 Musiał-Wysocka, Kot, Majka (CR46) 2019; 28 Wang (CR16) 2017; 8 Shree, Venkategowda, Venkatranganna, Datta, Bhonde (CR53) 2019; 2005 Mathew, Chandravanshi, Bhonde (CR79) 2017; 182 Isoda (CR55) 2006; 26 Roman (CR82) 2010; 314 Godisela (CR47) 2017; 23 Mathew, Bhonde (CR80) 2018; 132 Lee (CR23) 2006; 103 SA Mathew (96121_CR80) 2018; 132 F Hakuno (96121_CR38) 2018; 61 T TeSlaa (96121_CR87) 2014; 542 SK Mungamuri (96121_CR90) 2015; 34 DR Leitner (96121_CR4) 2017; 10 CF Deacon (96121_CR20) 2016; 18 MP Czech (96121_CR58) 2017; 23 A Hruby (96121_CR3) 2015; 33 T Luo (96121_CR18) 2016; 65 VT Samuel (96121_CR59) 2012; 148 R Jani (96121_CR41) 2008; 31 S Kadam (96121_CR22) 2010; 7 N Shree (96121_CR53) 2019; 2005 O Sarr (96121_CR48) 2017 S Usmani-Brown (96121_CR63) 2019; 27s J Wang (96121_CR16) 2017; 8 H Nasri (96121_CR56) 2014; 19 Y Si (96121_CR70) 2012; 61 AR Saltiel (96121_CR2) 2017; 127 V Venkatesan (96121_CR25) 2013; 2013 F Gao (96121_CR27) 2016; 7 MM Kamal (96121_CR28) 2020; 8 MJ Kraakman (96121_CR75) 2014; 5 VT Samuel (96121_CR7) 2010; 375 C Zheng (96121_CR85) 2015; 112 EA Roman (96121_CR82) 2010; 314 KK Godisela (96121_CR47) 2017; 23 A Taylor (96121_CR67) 2006; 117 H Lee (96121_CR78) 2013; 16 JM Argilés (96121_CR49) 2005; 25 Y Liu (96121_CR39) 2015; 64 XL Wang (96121_CR89) 2006; 55 A Chaudhury (96121_CR19) 2017; 8 SK Mungamuri (96121_CR86) 2016; 14 JR Krycer (96121_CR40) 2017; 21 DA Fruman (96121_CR37) 2017; 170 MF Pittenger (96121_CR42) 2019; 4 G Arango Duque (96121_CR12) 2014; 5 H Jiang (96121_CR88) 2019; 9 Y Liu (96121_CR26) 2011; 286 V Rotter (96121_CR69) 2003; 278 L Kern (96121_CR68) 2018 JO Lee (96121_CR54) 2012; 287 B Fève (96121_CR65) 2009; 5 SE Di Carlo (96121_CR76) 2018; 128 RH Lee (96121_CR23) 2006; 103 SK Fried (96121_CR73) 1998; 83 SW Lane (96121_CR77) 2014; 32 RS Ahima (96121_CR31) 2008; 118 H Sell (96121_CR66) 2012; 8 A Lecube (96121_CR84) 2006; 29 R Jiang (96121_CR21) 2011; 5 DH Ryan (96121_CR32) 2010; 170 M Beg (96121_CR57) 2017 N Harishankar (96121_CR24) 2011; 134 SA Mathew (96121_CR79) 2017; 182 SS Choe (96121_CR10) 2016; 7 L Pirola (96121_CR62) 2017; 8 M Li (96121_CR81) 2016; 7 LB Tanner (96121_CR35) 2018; 7 JN Fain (96121_CR72) 2004; 145 JP Bastard (96121_CR74) 2000; 85 G Rena (96121_CR13) 2017; 60 RS Hundal (96121_CR14) 2000; 49 KI Stanford (96121_CR50) 2018 SL Madhira (96121_CR36) 2012; 7 SJ Baek (96121_CR51) 2011; 43 IS Stafeev (96121_CR5) 2017; 2017 A Musiał-Wysocka (96121_CR46) 2019; 28 C Scheel (96121_CR44) 2011; 145 G Vallés (96121_CR52) 2020; 11 H Singh (96121_CR29) 2014; 6 N Wong (96121_CR83) 2011; 152 OT Hardy (96121_CR8) 2012; 19 N Rabbani (96121_CR60) 2019; 30 G Boden (96121_CR9) 2004; 27 K Isoda (96121_CR55) 2006; 26 A Asghar (96121_CR64) 2017; 315 BK Surmi (96121_CR11) 2008; 3 MY Donath (96121_CR61) 2013; 17 R Vijayalakshmi (96121_CR34) 1987; 24 M Mastri (96121_CR45) 2014; 6 S Polsky (96121_CR1) 2015; 22 P Bora (96121_CR33) 2017; 8 J Feng (96121_CR6) 2020; 13 KM Levri (96121_CR17) 2005; 3 FJ Lv (96121_CR43) 2014; 32 M Wang (96121_CR71) 2018; 26 TM Wallace (96121_CR30) 2004; 27 N Musi (96121_CR15) 2002; 51 34584190 - Sci Rep. 2021 Sep 28;11(1):19627 |
References_xml | – volume: 55 start-page: 2301 year: 2006 end-page: 2310 ident: CR89 article-title: Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase publication-title: Diabetes doi: 10.2337/db05-1574 – volume: 23 start-page: 263 year: 2017 end-page: 274 ident: CR47 article-title: Impact of obesity with impaired glucose tolerance on retinal degeneration in a rat model of metabolic syndrome publication-title: Mol. Vis. – volume: 29 start-page: 1096 year: 2006 end-page: 1101 ident: CR84 article-title: Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study publication-title: Diabetes Care doi: 10.2337/diacare.2951096 – volume: 34 start-page: 2461 year: 2015 end-page: 2470 ident: CR90 article-title: Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters publication-title: Oncogene doi: 10.1038/onc.2014.198 – volume: 27 start-page: 2253 year: 2004 end-page: 2259 ident: CR9 article-title: Lipids and glucose in type 2 diabetes: What is the cause and effect? publication-title: Diabetes Care doi: 10.2337/diacare.27.9.2253 – volume: 128 start-page: 54 year: 2018 end-page: 63 ident: CR76 article-title: The perivascular origin of pathological fibroblasts publication-title: J. Clin. Investig. doi: 10.1172/jci93558 – volume: 9 start-page: 2756 year: 2019 end-page: 2762 ident: CR88 article-title: A UPLC-MS/MS application for comparisons of the hepatotoxicity of raw and processed Xanthii Fructus by energy metabolites publication-title: RSC Adv. doi: 10.1039/C8RA08272C – volume: 148 start-page: 852 year: 2012 end-page: 871 ident: CR59 article-title: Mechanisms for insulin resistance: Common threads and missing links publication-title: Cell doi: 10.1016/j.cell.2012.02.017 – volume: 85 start-page: 3338 year: 2000 end-page: 3342 ident: CR74 article-title: Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.85.9.6839 – volume: 170 start-page: 146 year: 2010 end-page: 154 ident: CR32 article-title: Nonsurgical weight loss for extreme obesity in primary care settings: Results of the Louisiana Obese Subjects Study publication-title: Arch. Intern. Med. doi: 10.1001/archinternmed.2009.508 – volume: 7 start-page: 160 year: 2016 ident: CR81 article-title: In vivo human adipose-derived mesenchymal stem cell tracking after intra-articular delivery in a rat osteoarthritis model publication-title: Stem Cell Res.Ther doi: 10.1186/s13287-016-0420-2 – volume: 2013 start-page: 617569 year: 2013 ident: CR25 article-title: Obesity, insulin resistance, and metabolic syndrome: A study in WNIN/Ob rats from a pancreatic perspective publication-title: Biomed. Res. Int. doi: 10.1155/2013/617569 – volume: 21 start-page: 3536 year: 2017 end-page: 3547 ident: CR40 article-title: Dynamic metabolomics reveals that insulin primes the adipocyte for glucose metabolism publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.11.085 – volume: 278 start-page: 45777 year: 2003 end-page: 45784 ident: CR69 article-title: Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects publication-title: J. Biol. Chem. doi: 10.1074/jbc.M301977200 – volume: 8 start-page: 120 year: 2017 end-page: 128 ident: CR62 article-title: Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity publication-title: World J. Biol. Chem. doi: 10.4331/wjbc.v8.i2.120 – volume: 152 start-page: 3690 year: 2011 end-page: 3699 ident: CR83 article-title: Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice publication-title: Endocrinology doi: 10.1210/en.2011-0288 – volume: 4 start-page: 22 year: 2019 ident: CR42 article-title: Mesenchymal stem cell perspective: Cell biology to clinical progress publication-title: NPJ Regener. Med. doi: 10.1038/s41536-019-0083-6 – volume: 8 start-page: 709 year: 2012 end-page: 716 ident: CR66 article-title: Adaptive immunity in obesity and insulin resistance publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2012.114 – volume: 375 start-page: 2267 year: 2010 end-page: 2277 ident: CR7 article-title: Lipid-induced insulin resistance: Unravelling the mechanism publication-title: Lancet doi: 10.1016/s0140-6736(10)60408-4 – volume: 8 start-page: 98029 year: 2017 end-page: 98039 ident: CR16 article-title: Metformin ameliorates skeletal muscle insulin resistance by inhibiting miR-21 expression in a high-fat dietary rat model publication-title: Oncotarget doi: 10.18632/oncotarget.20442 – volume: 6 start-page: e998099 year: 2014 ident: CR29 article-title: Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats publication-title: Islets doi: 10.1080/19382014.2014.998099 – volume: 182 start-page: 85 year: 2017 end-page: 92 ident: CR79 article-title: Hypoxia primed placental mesenchymal stem cells for wound healing publication-title: Life Sci. doi: 10.1016/j.lfs.2017.06.016 – volume: 542 start-page: 91 year: 2014 end-page: 114 ident: CR87 article-title: Techniques to monitor glycolysis publication-title: Methods Enzymol. doi: 10.1016/b978-0-12-416618-9.00005-4 – volume: 3 start-page: 545 year: 2008 end-page: 556 ident: CR11 article-title: Macrophage infiltration into adipose tissue: iIitiation, propagation and remodeling publication-title: Futur. Lipidol. doi: 10.2217/17460875.3.5.545 – volume: 24 start-page: 329 year: 1987 end-page: 335 ident: CR34 article-title: Altered glucose metabolism in female rats treated with sex steroids: Reversal by excess pyridoxine publication-title: Indian J. Biochem. Biophys. – volume: 19 start-page: 658 year: 2014 end-page: 664 ident: CR56 article-title: Metformin: Current knowledge publication-title: J. Res. Med. Sci. – volume: 51 start-page: 2074 year: 2002 end-page: 2081 ident: CR15 article-title: Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.51.7.2074 – volume: 5 start-page: 94 year: 2011 end-page: 100 ident: CR21 article-title: Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: A pilot study publication-title: Front. Med. doi: 10.1007/s11684-011-0116-z – volume: 145 start-page: 2273 year: 2004 end-page: 2282 ident: CR72 article-title: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans publication-title: Endocrinology doi: 10.1210/en.2003-1336 – volume: 32 start-page: 795 year: 2014 end-page: 803 ident: CR77 article-title: Modulating the stem cell niche for tissue regeneration publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2978 – volume: 10 start-page: 483 year: 2017 end-page: 492 ident: CR4 article-title: Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies—EASO can lead the way publication-title: Obes. Facts doi: 10.1159/000480525 – volume: 3 start-page: 457 year: 2005 end-page: 461 ident: CR17 article-title: Metformin as treatment for overweight and obese adults: A systematic review publication-title: Ann. Fam. Med. doi: 10.1370/afm.343 – volume: 28 start-page: 801 year: 2019 end-page: 812 ident: CR46 article-title: The pros and cons of mesenchymal stem cell-based therapies publication-title: Cell Transplant. doi: 10.1177/0963689719837897 – volume: 25 start-page: 49 year: 2005 end-page: 65 ident: CR49 article-title: Cross-talk between skeletal muscle and adipose tissue: A link with obesity? publication-title: Med. Res. Rev. doi: 10.1002/med.20010 – volume: 49 start-page: 2063 year: 2000 end-page: 2069 ident: CR14 article-title: Mechanism by which metformin reduces glucose production in type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.49.12.2063 – volume: 127 start-page: 1 year: 2017 end-page: 4 ident: CR2 article-title: Inflammatory mechanisms linking obesity and metabolic disease publication-title: J. Clin. Investig. doi: 10.1172/jci92035 – volume: 43 start-page: 596 year: 2011 end-page: 603 ident: CR51 article-title: In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors publication-title: Exp. Mol. Med. doi: 10.3858/emm.2011.43.10.069 – volume: 13 start-page: 1399 year: 2020 end-page: 1406 ident: CR6 article-title: The role of JNk signaling pathway in obesity-driven insulin resistance publication-title: Diabetes Metab. Syndr. Obes. Targets Ther. doi: 10.2147/dmso.S236127 – year: 2018 ident: CR50 article-title: Muscle-adipose tissue cross talk publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a029801 – year: 2017 ident: CR48 article-title: Subcutaneous and visceral adipose tissue secretions from extremely obese men and women both acutely suppress muscle insulin signaling publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18050959 – volume: 287 start-page: 44121 year: 2012 end-page: 44129 ident: CR54 article-title: Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl/CAP signaling in 3T3-L1 preadipocyte cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.361386 – volume: 103 start-page: 17438 year: 2006 end-page: 17443 ident: CR23 article-title: Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.0608249103 – volume: 31 start-page: 311 year: 2008 end-page: 315 ident: CR41 article-title: Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range publication-title: Diabetes Care doi: 10.2337/dc07-1593 – volume: 8 start-page: 6 year: 2017 ident: CR19 article-title: Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management publication-title: Front. Endocrinol. doi: 10.3389/fendo.2017.00006 – volume: 286 start-page: 25007 year: 2011 end-page: 25015 ident: CR26 article-title: Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110.213108 – volume: 132 start-page: 90 year: 2018 end-page: 98 ident: CR80 article-title: Omega-3 polyunsaturated fatty acids promote angiogenesis in placenta derived mesenchymal stromal cells publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2018.04.002 – volume: 64 start-page: 4061 year: 2015 end-page: 4074 ident: CR39 article-title: Protein inhibitor of activated STAT 1 (PIAS1) protects against obesity-induced insulin resistance by inhibiting inflammation cascade in adipose tissue publication-title: Diabetes doi: 10.2337/db15-0278 – volume: 314 start-page: 62 year: 2010 end-page: 69 ident: CR82 article-title: Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism publication-title: Mol. Cell. Endocrinol. doi: 10.1016/j.mce.2009.08.007 – volume: 5 start-page: 470 year: 2014 ident: CR75 article-title: Macrophage polarization in obesity and type 2 diabetes: Weighing down our understanding of macrophage function? publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00470 – volume: 5 start-page: 491 year: 2014 ident: CR12 article-title: Macrophage cytokines: Involvement in immunity and infectious diseases publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00491 – volume: 65 start-page: 2295 year: 2016 end-page: 2310 ident: CR18 article-title: AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity publication-title: Diabetes doi: 10.2337/db15-1122 – volume: 7 start-page: e2062 year: 2016 ident: CR27 article-title: Mesenchymal stem cells and immunomodulation: Current status and future prospects publication-title: Cell Death Dis. doi: 10.1038/cddis.2015.327 – volume: 112 start-page: E7239 year: 2015 end-page: 7248 ident: CR85 article-title: CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.1500396113 – volume: 2017 start-page: 5076732 year: 2017 ident: CR5 article-title: Latent inflammation and insulin resistance in adipose tissue publication-title: Int. J. Endocrinol. doi: 10.1155/2017/5076732 – volume: 26 start-page: 1921 year: 2018 end-page: 1930 ident: CR71 article-title: Therapeutic effects of adipose stem cells from diabetic mice for the treatment of type 2 diabetes publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2018.06.013 – volume: 134 start-page: 320 year: 2011 end-page: 329 ident: CR24 article-title: WNIN/GR-Ob—an insulin-resistant obese rat model from inbred WNIN strain publication-title: Indian J. Med. Res. – year: 2017 ident: CR57 article-title: Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake publication-title: Elife doi: 10.7554/eLife.26896 – volume: 170 start-page: 605 year: 2017 end-page: 635 ident: CR37 article-title: The PI3K pathway in human disease publication-title: Cell doi: 10.1016/j.cell.2017.07.029 – volume: 145 start-page: 926 year: 2011 end-page: 940 ident: CR44 article-title: Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast publication-title: Cell doi: 10.1016/j.cell.2011.04.029 – volume: 19 start-page: 81 year: 2012 end-page: 87 ident: CR8 article-title: What causes the insulin resistance underlying obesity? publication-title: Curr. Opin. Endocrinol. Diabetes Obes. doi: 10.1097/MED.0b013e3283514e13 – volume: 118 start-page: 2380 year: 2008 end-page: 2383 ident: CR31 article-title: Revisiting leptin's role in obesity and weight loss publication-title: J. Clin. Investig. doi: 10.1172/jci36284 – volume: 7 start-page: 49 year: 2018 end-page: 62.e48 ident: CR35 article-title: Four key steps control glycolytic flux in mammalian cells publication-title: Cell Syst. doi: 10.1016/j.cels.2018.06.003 – volume: 14 start-page: 2528 year: 2016 end-page: 2537 ident: CR86 article-title: USP7 Enforces heterochromatinization of p53 target promoters by protecting SUV39H1 from MDM2-mediated degradation publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.02.049 – volume: 5 start-page: 305 year: 2009 end-page: 311 ident: CR65 article-title: The role of interleukins in insulin resistance and type 2 diabetes mellitus publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2009.62 – volume: 60 start-page: 1577 year: 2017 end-page: 1585 ident: CR13 article-title: The mechanisms of action of metformin publication-title: Diabetologia doi: 10.1007/s00125-017-4342-z – volume: 18 start-page: 333 year: 2016 end-page: 347 ident: CR20 article-title: Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas publication-title: Diabetes Obes. Metab. doi: 10.1111/dom.12610 – volume: 23 start-page: 804 year: 2017 end-page: 814 ident: CR58 article-title: Insulin action and resistance in obesity and type 2 diabetes publication-title: Nat. Med. doi: 10.1038/nm.4350 – volume: 16 start-page: 143 year: 2013 end-page: 152 ident: CR78 article-title: Obesity, inflammation and diet publication-title: Pediatr. Gastroenterol. Hepatol. Nutr. doi: 10.5223/pghn.2013.16.3.143 – volume: 61 start-page: 1616 year: 2012 end-page: 1625 ident: CR70 article-title: Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: Identification of a novel role in improving insulin sensitivity publication-title: Diabetes doi: 10.2337/db11-1141 – volume: 83 start-page: 847 year: 1998 end-page: 850 ident: CR73 article-title: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.83.3.4660 – volume: 6 start-page: 82 year: 2014 end-page: 93 ident: CR45 article-title: Enhancing the efficacy of mesenchymal stem cell therapy publication-title: World J. Stem Cells doi: 10.4252/wjsc.v6.i2.82 – volume: 7 start-page: 30 year: 2016 ident: CR10 article-title: Adipose tissue remodeling: Its role in energy metabolism and metabolic disorders publication-title: Front. Endocrinol. doi: 10.3389/fendo.2016.00030 – volume: 117 start-page: 433 year: 2006 end-page: 442 ident: CR67 article-title: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: The role of T regulatory cells publication-title: Immunology doi: 10.1111/j.1365-2567.2006.02321.x – volume: 26 start-page: 611 year: 2006 end-page: 617 ident: CR55 article-title: Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.Atv.0000201938.78044.75 – volume: 27s start-page: S104 year: 2019 end-page: S113 ident: CR63 article-title: β cell responses to inflammation publication-title: Mol. Metab. doi: 10.1016/j.molmet.2019.06.013 – volume: 32 start-page: 1408 year: 2014 end-page: 1419 ident: CR43 article-title: Concise review: The surface markers and identity of human mesenchymal stem cells publication-title: Stem Cells doi: 10.1002/stem.1681 – volume: 27 start-page: 1487 year: 2004 end-page: 1495 ident: CR30 article-title: Use and abuse of HOMA modeling publication-title: Diabetes Care doi: 10.2337/diacare.27.6.1487 – volume: 7 start-page: 168 year: 2010 end-page: 182 ident: CR22 article-title: Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes. The review of diabetic studies publication-title: RDS doi: 10.1900/rds.2010.7.168 – volume: 61 start-page: T69 year: 2018 end-page: t86 ident: CR38 article-title: IGF1 receptor signaling pathways publication-title: J. Mol. Endocrinol. doi: 10.1530/jme-17-0311 – volume: 8 start-page: 145 year: 2017 ident: CR33 article-title: Adipose tissue-derived stromal vascular fraction in regenerative medicine: A brief review on biology and translation publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-017-0598-y – volume: 11 start-page: 57 year: 2020 ident: CR52 article-title: Influence of inflammatory conditions provided by macrophages on osteogenic ability of mesenchymal stem cells publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-020-1578-1 – volume: 7 start-page: e48061 year: 2012 ident: CR36 article-title: Promise(s) of mesenchymal stem cells as an in vitro model system to depict pre-diabetic/diabetic milieu in WNIN/GR-Ob mutant rats publication-title: PLoS ONE doi: 10.1371/journal.pone.0048061 – volume: 17 start-page: 860 year: 2013 end-page: 872 ident: CR61 article-title: Inflammation in obesity and diabetes: Islet dysfunction and therapeutic opportunity publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.05.001 – year: 2018 ident: CR68 article-title: Obesity-induced TNFα and IL-6 signaling: The missing link between obesity and inflammation-driven liver and colorectal cancers publication-title: Cancers doi: 10.3390/cancers11010024 – volume: 22 start-page: 277 year: 2015 end-page: 282 ident: CR1 article-title: Obesity, insulin resistance, and type 1 diabetes mellitus publication-title: Curr. Opin. Endocrinol. Diabetes Obes. doi: 10.1097/med.0000000000000170 – volume: 8 start-page: 16 year: 2020 ident: CR28 article-title: Therapeutic potential of Wharton's jelly mesenchymal stem cells for diabetes: Achievements and challenges publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2020.00016 – volume: 2005 start-page: 2107 issue: 43 year: 2019 end-page: 2118 ident: CR53 article-title: Human adipose tissue mesenchymal stem cells as a novel treatment modality for correcting obesity induced metabolic dysregulation publication-title: Int. J. Obes. doi: 10.1038/s41366-019-0438-5 – volume: 33 start-page: 673 year: 2015 end-page: 689 ident: CR3 article-title: The epidemiology of obesity: A big picture publication-title: Pharmacoeconomics doi: 10.1007/s40273-014-0243-x – volume: 315 start-page: 18 year: 2017 end-page: 26 ident: CR64 article-title: Role of immune cells in obesity induced low grade inflammation and insulin resistance publication-title: Cell. Immunol. doi: 10.1016/j.cellimm.2017.03.001 – volume: 30 start-page: 419 year: 2019 end-page: 431 ident: CR60 article-title: Hexokinase-2 glycolytic overload in diabetes and ischemia-reperfusion injury publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2019.04.011 – volume: 8 start-page: 16 year: 2020 ident: 96121_CR28 publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2020.00016 – volume: 27 start-page: 2253 year: 2004 ident: 96121_CR9 publication-title: Diabetes Care doi: 10.2337/diacare.27.9.2253 – volume: 30 start-page: 419 year: 2019 ident: 96121_CR60 publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2019.04.011 – volume: 6 start-page: e998099 year: 2014 ident: 96121_CR29 publication-title: Islets doi: 10.1080/19382014.2014.998099 – volume: 28 start-page: 801 year: 2019 ident: 96121_CR46 publication-title: Cell Transplant. doi: 10.1177/0963689719837897 – volume: 10 start-page: 483 year: 2017 ident: 96121_CR4 publication-title: Obes. Facts doi: 10.1159/000480525 – volume: 128 start-page: 54 year: 2018 ident: 96121_CR76 publication-title: J. Clin. Investig. doi: 10.1172/jci93558 – volume: 17 start-page: 860 year: 2013 ident: 96121_CR61 publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.05.001 – volume: 61 start-page: T69 year: 2018 ident: 96121_CR38 publication-title: J. Mol. Endocrinol. doi: 10.1530/jme-17-0311 – volume: 43 start-page: 596 year: 2011 ident: 96121_CR51 publication-title: Exp. Mol. Med. doi: 10.3858/emm.2011.43.10.069 – volume: 60 start-page: 1577 year: 2017 ident: 96121_CR13 publication-title: Diabetologia doi: 10.1007/s00125-017-4342-z – volume: 127 start-page: 1 year: 2017 ident: 96121_CR2 publication-title: J. Clin. Investig. doi: 10.1172/jci92035 – volume: 8 start-page: 6 year: 2017 ident: 96121_CR19 publication-title: Front. Endocrinol. doi: 10.3389/fendo.2017.00006 – year: 2018 ident: 96121_CR50 publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a029801 – volume: 16 start-page: 143 year: 2013 ident: 96121_CR78 publication-title: Pediatr. Gastroenterol. Hepatol. Nutr. doi: 10.5223/pghn.2013.16.3.143 – volume: 19 start-page: 658 year: 2014 ident: 96121_CR56 publication-title: J. Res. Med. Sci. – volume: 21 start-page: 3536 year: 2017 ident: 96121_CR40 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.11.085 – volume: 118 start-page: 2380 year: 2008 ident: 96121_CR31 publication-title: J. Clin. Investig. doi: 10.1172/jci36284 – year: 2017 ident: 96121_CR57 publication-title: Elife doi: 10.7554/eLife.26896 – volume: 24 start-page: 329 year: 1987 ident: 96121_CR34 publication-title: Indian J. Biochem. Biophys. – volume: 7 start-page: 30 year: 2016 ident: 96121_CR10 publication-title: Front. Endocrinol. doi: 10.3389/fendo.2016.00030 – volume: 13 start-page: 1399 year: 2020 ident: 96121_CR6 publication-title: Diabetes Metab. Syndr. Obes. Targets Ther. doi: 10.2147/dmso.S236127 – volume: 25 start-page: 49 year: 2005 ident: 96121_CR49 publication-title: Med. Res. Rev. doi: 10.1002/med.20010 – volume: 4 start-page: 22 year: 2019 ident: 96121_CR42 publication-title: NPJ Regener. Med. doi: 10.1038/s41536-019-0083-6 – volume: 11 start-page: 57 year: 2020 ident: 96121_CR52 publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-020-1578-1 – volume: 64 start-page: 4061 year: 2015 ident: 96121_CR39 publication-title: Diabetes doi: 10.2337/db15-0278 – volume: 34 start-page: 2461 year: 2015 ident: 96121_CR90 publication-title: Oncogene doi: 10.1038/onc.2014.198 – volume: 148 start-page: 852 year: 2012 ident: 96121_CR59 publication-title: Cell doi: 10.1016/j.cell.2012.02.017 – volume: 3 start-page: 457 year: 2005 ident: 96121_CR17 publication-title: Ann. Fam. Med. doi: 10.1370/afm.343 – volume: 152 start-page: 3690 year: 2011 ident: 96121_CR83 publication-title: Endocrinology doi: 10.1210/en.2011-0288 – volume: 117 start-page: 433 year: 2006 ident: 96121_CR67 publication-title: Immunology doi: 10.1111/j.1365-2567.2006.02321.x – volume: 2017 start-page: 5076732 year: 2017 ident: 96121_CR5 publication-title: Int. J. Endocrinol. doi: 10.1155/2017/5076732 – volume: 23 start-page: 263 year: 2017 ident: 96121_CR47 publication-title: Mol. Vis. – volume: 5 start-page: 491 year: 2014 ident: 96121_CR12 publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00491 – volume: 14 start-page: 2528 year: 2016 ident: 96121_CR86 publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.02.049 – volume: 7 start-page: e2062 year: 2016 ident: 96121_CR27 publication-title: Cell Death Dis. doi: 10.1038/cddis.2015.327 – volume: 33 start-page: 673 year: 2015 ident: 96121_CR3 publication-title: Pharmacoeconomics doi: 10.1007/s40273-014-0243-x – volume: 8 start-page: 145 year: 2017 ident: 96121_CR33 publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-017-0598-y – volume: 182 start-page: 85 year: 2017 ident: 96121_CR79 publication-title: Life Sci. doi: 10.1016/j.lfs.2017.06.016 – volume: 5 start-page: 305 year: 2009 ident: 96121_CR65 publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2009.62 – volume: 65 start-page: 2295 year: 2016 ident: 96121_CR18 publication-title: Diabetes doi: 10.2337/db15-1122 – volume: 315 start-page: 18 year: 2017 ident: 96121_CR64 publication-title: Cell. Immunol. doi: 10.1016/j.cellimm.2017.03.001 – volume: 132 start-page: 90 year: 2018 ident: 96121_CR80 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2018.04.002 – volume: 170 start-page: 605 year: 2017 ident: 96121_CR37 publication-title: Cell doi: 10.1016/j.cell.2017.07.029 – volume: 170 start-page: 146 year: 2010 ident: 96121_CR32 publication-title: Arch. Intern. Med. doi: 10.1001/archinternmed.2009.508 – volume: 26 start-page: 1921 year: 2018 ident: 96121_CR71 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2018.06.013 – volume: 31 start-page: 311 year: 2008 ident: 96121_CR41 publication-title: Diabetes Care doi: 10.2337/dc07-1593 – year: 2017 ident: 96121_CR48 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18050959 – volume: 287 start-page: 44121 year: 2012 ident: 96121_CR54 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.361386 – volume: 134 start-page: 320 year: 2011 ident: 96121_CR24 publication-title: Indian J. Med. Res. – volume: 5 start-page: 470 year: 2014 ident: 96121_CR75 publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00470 – volume: 286 start-page: 25007 year: 2011 ident: 96121_CR26 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110.213108 – volume: 29 start-page: 1096 year: 2006 ident: 96121_CR84 publication-title: Diabetes Care doi: 10.2337/diacare.2951096 – volume: 2013 start-page: 617569 year: 2013 ident: 96121_CR25 publication-title: Biomed. Res. Int. doi: 10.1155/2013/617569 – volume: 61 start-page: 1616 year: 2012 ident: 96121_CR70 publication-title: Diabetes doi: 10.2337/db11-1141 – volume: 9 start-page: 2756 year: 2019 ident: 96121_CR88 publication-title: RSC Adv. doi: 10.1039/C8RA08272C – volume: 19 start-page: 81 year: 2012 ident: 96121_CR8 publication-title: Curr. Opin. Endocrinol. Diabetes Obes. doi: 10.1097/MED.0b013e3283514e13 – volume: 2005 start-page: 2107 issue: 43 year: 2019 ident: 96121_CR53 publication-title: Int. J. Obes. doi: 10.1038/s41366-019-0438-5 – year: 2018 ident: 96121_CR68 publication-title: Cancers doi: 10.3390/cancers11010024 – volume: 145 start-page: 926 year: 2011 ident: 96121_CR44 publication-title: Cell doi: 10.1016/j.cell.2011.04.029 – volume: 8 start-page: 120 year: 2017 ident: 96121_CR62 publication-title: World J. Biol. Chem. doi: 10.4331/wjbc.v8.i2.120 – volume: 26 start-page: 611 year: 2006 ident: 96121_CR55 publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.Atv.0000201938.78044.75 – volume: 83 start-page: 847 year: 1998 ident: 96121_CR73 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.83.3.4660 – volume: 542 start-page: 91 year: 2014 ident: 96121_CR87 publication-title: Methods Enzymol. doi: 10.1016/b978-0-12-416618-9.00005-4 – volume: 7 start-page: 49 year: 2018 ident: 96121_CR35 publication-title: Cell Syst. doi: 10.1016/j.cels.2018.06.003 – volume: 314 start-page: 62 year: 2010 ident: 96121_CR82 publication-title: Mol. Cell. Endocrinol. doi: 10.1016/j.mce.2009.08.007 – volume: 55 start-page: 2301 year: 2006 ident: 96121_CR89 publication-title: Diabetes doi: 10.2337/db05-1574 – volume: 6 start-page: 82 year: 2014 ident: 96121_CR45 publication-title: World J. Stem Cells doi: 10.4252/wjsc.v6.i2.82 – volume: 32 start-page: 795 year: 2014 ident: 96121_CR77 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2978 – volume: 112 start-page: E7239 year: 2015 ident: 96121_CR85 publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.1500396113 – volume: 7 start-page: 168 year: 2010 ident: 96121_CR22 publication-title: RDS doi: 10.1900/rds.2010.7.168 – volume: 32 start-page: 1408 year: 2014 ident: 96121_CR43 publication-title: Stem Cells doi: 10.1002/stem.1681 – volume: 8 start-page: 709 year: 2012 ident: 96121_CR66 publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2012.114 – volume: 145 start-page: 2273 year: 2004 ident: 96121_CR72 publication-title: Endocrinology doi: 10.1210/en.2003-1336 – volume: 49 start-page: 2063 year: 2000 ident: 96121_CR14 publication-title: Diabetes doi: 10.2337/diabetes.49.12.2063 – volume: 51 start-page: 2074 year: 2002 ident: 96121_CR15 publication-title: Diabetes doi: 10.2337/diabetes.51.7.2074 – volume: 375 start-page: 2267 year: 2010 ident: 96121_CR7 publication-title: Lancet doi: 10.1016/s0140-6736(10)60408-4 – volume: 103 start-page: 17438 year: 2006 ident: 96121_CR23 publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.0608249103 – volume: 85 start-page: 3338 year: 2000 ident: 96121_CR74 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.85.9.6839 – volume: 18 start-page: 333 year: 2016 ident: 96121_CR20 publication-title: Diabetes Obes. Metab. doi: 10.1111/dom.12610 – volume: 23 start-page: 804 year: 2017 ident: 96121_CR58 publication-title: Nat. Med. doi: 10.1038/nm.4350 – volume: 8 start-page: 98029 year: 2017 ident: 96121_CR16 publication-title: Oncotarget doi: 10.18632/oncotarget.20442 – volume: 27s start-page: S104 year: 2019 ident: 96121_CR63 publication-title: Mol. Metab. doi: 10.1016/j.molmet.2019.06.013 – volume: 3 start-page: 545 year: 2008 ident: 96121_CR11 publication-title: Futur. Lipidol. doi: 10.2217/17460875.3.5.545 – volume: 5 start-page: 94 year: 2011 ident: 96121_CR21 publication-title: Front. Med. doi: 10.1007/s11684-011-0116-z – volume: 7 start-page: e48061 year: 2012 ident: 96121_CR36 publication-title: PLoS ONE doi: 10.1371/journal.pone.0048061 – volume: 278 start-page: 45777 year: 2003 ident: 96121_CR69 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M301977200 – volume: 22 start-page: 277 year: 2015 ident: 96121_CR1 publication-title: Curr. Opin. Endocrinol. Diabetes Obes. doi: 10.1097/med.0000000000000170 – volume: 27 start-page: 1487 year: 2004 ident: 96121_CR30 publication-title: Diabetes Care doi: 10.2337/diacare.27.6.1487 – volume: 7 start-page: 160 year: 2016 ident: 96121_CR81 publication-title: Stem Cell Res.Ther doi: 10.1186/s13287-016-0420-2 – reference: 34584190 - Sci Rep. 2021 Sep 28;11(1):19627 |
SSID | ssj0000529419 |
Score | 2.3563547 |
Snippet | Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy... Abstract Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 16983 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase 631/45/127 631/45/320 631/532 631/532/2074 631/80/86/2367 Adipocytes Adipocytes - metabolism Adipose tissue Adipose Tissue - metabolism AKT protein Animals Blood glucose Blood Glucose - metabolism Cell therapy Cells, Cultured Cytokines Cytokines - metabolism Diabetes mellitus Diabetes Mellitus, Experimental - blood Diabetes Mellitus, Experimental - prevention & control Diabetes Mellitus, Experimental - therapy Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - etiology Diabetes Mellitus, Type 2 - prevention & control Diabetes Mellitus, Type 2 - therapy Female Glucose Glucose Transporter Type 4 - metabolism Homeostasis Humanities and Social Sciences Humans Insulin Insulin - metabolism Insulin resistance Macrophages - metabolism Mesenchymal Stem Cell Transplantation Mesenchymal stem cells Mesenchymal Stem Cells - cytology Metabolic disorders Metabolic syndrome Models, Biological multidisciplinary Obesity - complications Palmitic acid Peripheral blood Phosphatidylinositol 3-Kinases - metabolism Placenta Placenta - cytology Pregnancy Protein Transport Proto-Oncogene Proteins c-akt - metabolism Rats Risk factors Science Science (multidisciplinary) Signal Transduction Stem cells Therapeutic applications |
SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9UwFA4yILgR31ZHieBC0TJpkiatOxWHQdCVA7MLeToXZtph7p2Bu_Sfe07SXuf63LgppT0pId9J8qXJ-Q4hz7WQQAKiq7lsfS07z2rXOF4rnQBvn2yKGI386bM6OJQfj9qjK6m-8ExYkQcuDbfHQvC-ZSxJGaXjqlNO9ilq3TZRy5hHX5jzriymiqo372XTT1EyTHR7S5ipMJoMTySgalbNtmaiLNj_O5b562HJn3ZM80S0f4vcnBgkfVtqfptci8Mdcr3klFzfJd8AeArfB_zii-VLOiZ6ihFG_nh9CsVQt5ni33paIq_WdDFQm5MyD1-hXJxDJen8V_YNPYHREJyTYigKml8uLkdqh1DuV-cjzfl0aFGFXt4jh_sfvrw_qKc8C7UHvraqA_fQtXHHE9hCl4JwVkXhleqTAkrkXfBWS-BRzlrug2c2wdVKyYJolQ3iPtkZxiE-JJTFAGapDwFXux23qRcihUYFhzGwuiLN3ObGTyLkmAvjxOTNcNGZgpMBnEzGybCKvNqUOSsSHH-1fodQbixRPjs_AKcyk1OZfzlVRXZnRzBTn14ajlJqive6r8izzWtAE0GzQxwvio3kwKrhEw-K32xqIjDbG_Dbiugtj9qq6vabYXGcFb87oXvOZEVez773o1p_bopH_6MpHpMbHDsNwwF1l-yszi_iE-BhK_c0d7nvQ6kvyQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4t1AQUbiAIKoju3YCRcEiKpCghOV9mb52a7UJmWzrbRH_jkzeVXLo5fVajOOvPlm7C8znhlCXmkhgQREl3NZ-lxWnuWucDxXOgHePtkUMRv523d1eCS_LsrF6HDrxmOV05rYL9Sh9egj3-dYyErxWtcfzn_m2DUKo6tjC42b5BaWLkOt1gs9-1gwiiWLesyVYaLa72C_wpwyPJeAtbNytrUf9WX7_8U1_z4y-UfctN-ODu6RuyOPpB8H4O-TG7F5QG4PnSU3D8kvgJ_C_QHF-Lp7Q9tEzzDPyJ9szmAYVm-m6LOnQ_7Vhi4bavvWzM0xjItTwiSdfLPv6SmsiaCiFBNSUPxyedlS24Th-3rV0r6rDh1qQ3ePyNHBlx-fD_Ox20LugbWt88A9GDjGPYEzVCkIZ1UUXqk6KSBG3gVvtQQ25azlPnhmE3xaKVkQpbJBPCY7TdvEXUJZDCCW6hDwnbfiNtVCpFCo4DATVmekmJ658WMpcuyIcWr6kLiozICTAZxMj5NhGXk7jzkfCnFcK_0JoZwlsYh2_0O7OjajTRoWgvclY0nKKB1XlXKyTlHrsohaRp6RvUkRzGjZnbnSw4y8nC8DmgiabWJ7MchIDtwabvFk0Jt5JgJ7vgHLzYje0qitqW5faZYnfd3vSuiaM5mRd5PuXU3r_4_i6fX_4hm5w9EcGC6Ye2RnvbqIz4Fnrd2L3ph-A1ujJzk priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9UwFA7DDIIb8W11lAguFC2mSZq07q7iMFzQjQ7MruQ5c8Fp5fbOwF36zz0nfcjVUXBTSntSQr6T5svjfIeQF1pIIAHB5lyWLpeVY7ktLM-VjoC3iyYGjEb-9Fkdn8jlaXm6R_gUC5MO7SdJy_Sbnk6Hve1hoMFgMDxQgKJXOUzTD1CqHXz7YLFYflnOKyu4dyWLeoyQYaK6pvDOKJTE-q9jmH8elPxttzQNQke3ya2RPdLFUN87ZC-0d8mNIZ_k9h75AaBT-D5gF172r2gX6QVGF7nz7QUUQ81miiv1dIi62tJVS01KyNyeQbkwhUnSaUX2HYVWAUbeUwxDQfOr1VVHTeuH-826oymXDh0Uofv75OTo49cPx_mYYyF3wNU2uecOujXudgJTqKIX1qggnFJ1VECHnPXOaAkcyhrDnXfMRLgaKZkXpTJePCD7bdeGR4Sy4MEs1t7jTLfiJtZCRF8obzH-VWekmNq8caMAOebB-NakjXBRNQNODeDUJJwalpHXc5nvg_zGP63fI5SzJUpnpwfd-qwZXalh3jtXMhalDNJyVSkr6xi0LougZeAZOZwcoRn7c99wlFFTvNZ1Rp7PrwFNBM20obscbCQHRg2feDj4zVwTgZnegNtmRO941E5Vd9-0q_Ok9l0JXXMmM_Jm8r1f1fp7Uzz-P_Mn5CbH7sHwt3lI9jfry_AU2NbGPhu7109BSSZI priority: 102 providerName: Springer Nature |
Title | The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems |
URI | https://link.springer.com/article/10.1038/s41598-021-96121-0 https://www.ncbi.nlm.nih.gov/pubmed/34417511 https://www.proquest.com/docview/2563062979 https://www.proquest.com/docview/2563421392 https://pubmed.ncbi.nlm.nih.gov/PMC8379204 https://doaj.org/article/0ddcc500f44e4b2686b49fe7751e74e2 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELfGJiReEN8ERmUkHkAQ5jqOnSAh1FWbpkqbEFCpb5Hjj61Sl0DbTfSR_5y7OCkqFCRekig-R5bvLv75435HyAuVCAABroy5SE0sMsPisl_yWCoP-jZee4fRyKdn8mQsRpN0skO6dEdtBy62Tu0wn9R4Pnv7_dvqAzj8-xAynh0sYBDCQDE8bICEWDFM4fdgZFKY0eC0hfuB65vnop-3sTPbq26MTw2N_zbs-ecRyt_2UZvh6fgOud3iSjoIhnCX7LjqHrkZMk2u7pMfYA4Uvg9adS8Xr2jt6SXGHZmL1SVUQzZnimv4NMRjrei0orpJ1VydQz3XBVDSbq32HZ3BPxJMlmKACopfT69rqisbnpfzmjZZdmjgil48IOPjoy_Dk7jNvhAbQHHL2HIDDo_7oIAhMm-TUkuXGClzLwEomdIarQSgq1Jrbqxh2sNVC8Fskkptk4dkt6or95hQ5iyI-dxanANnXPs8SbztS1tiZKyKSL_r88K01OSYIWNWNFvkSVYEPRWgp6LRU8Ei8npd52sg5vin9CGqci2JpNrNi3p-XrQ-WjBrjUkZ80I4UXKZyVLk3imV9p0SjkdkvzOEojPUgiPBmuS5yiPyfF0M2kSl6crVV0FGcMDa8IlHwW7WLUkwBxyg3oioDYvaaOpmSTW9aHjAs0TlnImIvOls71ez_t4VT_5P_Cm5xdE9GP5Q98nucn7lngEOW5Y9ckNNVI_sDQajzyO4Hx6dffwEb4dy2GvWNnqN-_0ECp40ag |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKEYKXipuUAkYCCQRRvbbXTpAQ4qq29HhqpX1zHR_tSm1SdrdF-8gf4jcyk2Or5ehbX6IoGVtO5vPM2OOZIeSFFhKMgFCkXPZdKjPH0qJX8FTpCPx20caA0cg7u2qwL78N-8Ml8quLhcFjlZ1MrAW1rxzuka9zTGSleK7zD6ffU6wahd7VroRGA4utMPsBS7bJ-80vwN-XnG983fs8SNuqAqkD62Saeu4AyOjfA92YRS8Kq4JwSuVRgQHgCu-slmA1FNZy5x2zEa5WSuZFX1kvoN9r5DooXoaLPT3U8z0d9JrJXt7G5jCRrU9AP2IMG56DwFxdKVvQf3WZgH_Ztn8f0fzDT1urv43bZKW1W-nHBmh3yFIo75IbTSXL2T3yE-BGoX9ATXg1eU2rSE8wrskdzU6gGWaLpugjoE2814yOSmrrUtDlIbQLXYAm7faC39FjkMEwJSgGwCD5-ei8orb0zf10XNG6ig9tclFP7pP9K-HDA7JcVmV4RCgLHshi7j2usTNuYy5E9D3lC4y81Qnpdf_cuDb1OVbgODa1C15kpuGTAT6Zmk-GJeTNvM1pk_jjUupPyMo5JSbtrh9U40PTygDDvHeuz1iUMsiCq0wVMo9B634vaBl4QtY6IJhWkkzMBe4T8nz-GriJTLNlqM4aGsnBlocuHja4mY9EYI05sKoTohcQtTDUxTfl6KjOM54JnXMmE_K2w97FsP7_K1Yv_4pn5OZgb2fbbG_ubj0mtzhODYbCeo0sT8dn4QnYeNPiaT2xKDm46pn8G44SZXg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELbKViBeKm5SChgJJBCN1mt7nQQJIUq7aimsKkSlvhnHR7tSm5TdbdE-8rf4dczk2Go5-taXKErGlpM5PPb4myHkeSIkOAE-j7ns21imlsV5L-exSgLw2wYTPKKRPw_V9r78eNA_WCK_WiwMHqtsbWJlqF1pcY-8yzGRleJZknVDcyxib3Pw7vR7jBWkMNLaltOoRWTXz37A8m3ydmcTeP2C88HW1w_bcVNhILbgqUxjxy0INcb6YJ5MgxO5UV5YpbKgwBmwubMmkeBB5MZw6ywzAa5GSuZEXxknoN9rZDnBVVGHLG9sDfe-zHd4MIYme1mD1GEi7U5gtkREG56KwMxdMVuYDauiAf_ydP8-sPlH1LaaDAe3yErjxdL3tdjdJku-uEOu13UtZ3fJTxA-Cv2DDPmXk1e0DPQEUU72aHYCzTB3NMWIAa3RXzM6KqipCkMXh9DOt3BN2u4Mv6HHYJFBQSjCYZD8fHReUlO4-n46LmlV04fWmakn98j-lXDiPukUZeEfEsq8A7KQOYcr7pSbkAkRXE-5HHG4SUR67T_XtkmEjvU4jnUVkBeprvmkgU-64pNmEXk9b3NapwG5lHoDWTmnxBTe1YNyfKgbi6CZc9b2GQtSeplzlapcZsEnSb_nE-l5RNZaQdCNXZnoCy2IyLP5a-AmMs0UvjyraSQHzx66eFDLzXwkAivOgY8dkWRBohaGuvimGB1VWcdTkWScyYist7J3Maz__4rVy7_iKbkBWqw_7Qx3H5GbHDWDoeVeI53p-Mw_Bodvmj9pNIuSb1etzL8BQKhrEw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+promise%28s%29+of+mesenchymal+stem+cell+therapy+in+averting+preclinical+diabetes%3A+lessons+from+in+vivo+and+in+vitro+model+systems&rft.jtitle=Scientific+reports&rft.au=Kotikalapudi%2C+Nagasuryaprasad&rft.au=Sampath%2C+Samuel+Joshua+Pragasam&rft.au=Sukesh+Narayan%2C+Sinha&rft.au=R.%2C+Bhonde&rft.date=2021-08-20&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-96121-0&rft.externalDocID=10_1038_s41598_021_96121_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |